[Control rate of increased low-density lipoprotein cholesterol levels in cardiology outpatients with coronary heart disease in Beijing].

OBJECTIVE: To investigate the low-density lipoprotein cholesterol (LDL-C) levels in outpatients with coronary heart disease (CHD) visiting cardiology outpatient clinics of 8 hospitals in Beijing. METHODS: A total of 903 outpatients with CHD were enrolled from 4 three-tier hospitals and 4 two-tier hospitals in Beijing. All patients were asked to finish the questionnaire including demographic data, CHD history, the knowledge on cholesterol, and the use of statins. Blood lipid was examined and the LDL-C control rate and related factors were then analyzed. RESULTS: Questionnaire was obtained from 876 patients [619 male: 70.7%, mean age: (64.9 ± 10.7) years old] and blood lipid data were available in 709 patients. The general LDL-C control rate was 36.9% (262/709) and was 13.5% (27/173) in very high risk CHD patients, and lower in patients treated in two-tier hospitals than patients treated in three-tier hospitals[31.3% (121/386) vs. 43.7% (141/323), P < 0.01], in female patients than in male patients [27.1% (60/261) vs. 41.3% (201/496), P < 0.01] and in diabetic patients than in non-diabetic patients [13.5% (27/200) vs. 44.7% (197/441), P < 0.01]. The LDL-C control rate was lower in patients less than 60 years old and patients over 80 years old than that in 60-70 years old patients and 70 - 80 years old patients (P < 0.05). LDL-C control rate was not affected by the history of hypertension, percutaneous coronary intervention or coronary artery bypass grafting, smoking, lipid examination frequency, knowledge on goal level of LDL-C, diet control and regularly physical exercising (all P > 0.05). There were 18.2% (129/709) patients not taking statins or not aware if they were taking statin or not. The main reason for not taking statin [47.9% (23/48)] was statin was no prescribed by doctors, followed by withdrawal by patients due to various reasons [27.1% (13/48)]. CONCLUSIONS: LDL-C control rate was low in patients with CHD visiting cardiology outpatient clinics in Beijing. The CHD patients and cardiologists should be encouraged to achieve better LDL-C control by following lipid lowering guidelines and it is also important to improve the drug compliance among CHD patients.

[Distribution and sources of arsenic in Yangzonghai Lake, China].

By collecting water and sediment samples from Yangzonghai Lake and analyzing the total amount and speciation of arsenic, the spatial distribution of arsenic in surface water and sediments was analyzed, the current status of arsenic pollution were estimated, the anthropogenic contribution rate and the arsenic reserve in the lake were calculated respectively. Meanwhile, the sources of arsenic were investigated. The results indicated that the total arsenic content in Yangzonghai Lake was 71.96-101.2 microg x L(-1) in April, 2010, and increased slightly with depth. Dissolved arsenic content was 68.14-96.72 microg x L(-1), with As (III) accounting for 32%. The health risk level of arsenic in the water was 4.77 x 10(-4) - 6.66 x 10(-4) a(-1), posing a considerable threat to the surrounding environment. Arsenic content in sediments lied between 6.05-396.49 mg x kg(-1). In sediments at the depths of 0-2, 2-4, 4-6, 6-8 and 8-10 cm, the average arsenic contents were 155.66, 52.01, 29.78, 19.22 and 17.52 mg x kg(-1) respectively. Arsenic in sediments at 0-2 cm had the highest accumulation degree, with the maximum geoaccumulation index up to 5. At the deeper depths, the accumulation degree of arsenic significantly lowered. The sequence of arsenic average contents of seven forms in sediments in the descending order is residual fraction, humic acids fraction, oxide fraction, strong organic fraction, ion exchange fraction, water soluble fraction and carbonate fraction. With increase of sediments depths, the percentage of bioavailable arsenic decreased, and the percentage of residual fraction arsenic increased rapidly. The anthropogenic contribution rate of arsenic in sediments was the highest at 0-2 cm depth, with average of 81.94%. This rate was much lower at the deeper depths. Currently, the total arsenic reserve in water and sediments of Yangzonghai Lake was 70.65 t, of which 82.68% was contributed by human activities. The phosphate fertilizer plant on the south bank made the greatest contribution to arsenic accumulation in Yangzonghai Lake, followed by golf course on the east bank, thermal power station and hot spring on the north bank.

[Preliminary observation on survival and reproduction of imported Oncomelania snails in water network regions: a simulated experiment].

OBJECTIVE: To observe the survival and reproduction of exotic imported Oncomelania snails in water network regions. METHODS: During a period between May 22, 2008 and August 7, 2009, a study pilot was established in a historical snail habitat in Qingpu District of Shanghai City. A total of 12 soil samples were collected from Qingpu, Jinshan and Songjiang districts and placed in the study area. Active marked adults snails without infections (with a female/male ratio of 1) were placed on soil surface, and the activity, survival and reproduction of snails on soil surface were observed. The temperature during the period of the study was recorded. RESULTS: During the experiment period, the highest temperature was 39 degrees C, the lowest was -3 degrees C, and the average was 20 degrees C. The activity of snails reduced significantly on the soil surface at high temperature in summer and low temperature in winter. There were 91 old snails (5.2%) that moved on soil surface in March and 73 (12.2% ) in June, 2009. A total of 26 and 59 offspring snails were found respectively in April and June, 2009, with average density of 2.17 snails/m2 (26/12) and 4.92 snails/m2 (59/12) respectively. CONCLUSIONS: The exotic imported snails can survive and reproduce in water network regions. Further monitoring should be strengthened on the imported snails in these regions.

Comparison of changes in early inflammatory markers between sirolimus- and paclitaxel-eluting stent implantation.

BACKGROUND: Systemic inflammation after coronary intervention identifies patients at increased risk of subsequent cardiac events. Cardiac events, especially in-stent restenosis, are less frequent after use of sirolimus-eluting stent (SES) compared with paclitaxel-eluting stent (PES). However, the underlying mechanism for this disparity is not well investigated. We hypothesize that an attenuated inflammatory response after SES implantation may be a contributor. PURPOSE: In the present study, we sought to determine the early inflammatory response after SES implantation in patients with single-vessel disease compared with PES implantation, and evaluate the relationship between inflammatory response and late clinical outcomes in a randomized design. METHODS: Thirty-two patients with stable angina were randomly enrolled into the two groups, SES or PSE group (n = 16 respectively). Peripheral blood samples were taken before PCI, 24 and 72 h after stenting. The plasma concentrations of C-reactive protein (CRP) and interleukin-6 (IL-6) were determined by enzyme-linked immunosorbent assay (ELISA). The clinical and angiographic follow-up was performed at 8 months after stenting. RESULTS: The data showed that there was no significant difference in clinical and angiographic baseline characteristics between the two groups. The plasma CRP and IL-6 levels at 24 h after stenting were significant higher in both groups compared with baseline (p < 0.01 respectively). Likewise, the CRP levels at 72 h after stenting were also significant higher compared with baseline in both groups (p < 0.01 respectively). However, the plasma levels of IL-6 at 24 h and CRP at 72 h after stenting were higher in PES group compared with SES group (p < 0.05). At 8 months follow-up, the rates of major adverse cardiac events, target lesion revascularization, in-stent and in-segment restenosis were similar in both groups. However, the late loss in both in-stent and in-segment was significantly higher in the PES group than in SES group (p < 0.001 respectively). CONCLUSIONS: Our findings suggest that a drug-eluting stent implantation could trigger a systemic inflammatory response as previously demonstrated. However, SES implantation results in a lower inflammatory response compared with PES implantation, which seems to be associated with greater late of in-stent and in-segment loss at 8-month follow-up with PES.

[Relation of risk factors to coronary artery stenosis severity in coronary atherosclerotic heart disease].

OBJECTIVE: To study the relationship of the risk factors to the coronary artery stenosis severity in coronary atherosclerotic heart disease (CAD). METHODS: 286 CAD patients, 206 males and 80 females, aged 61.6, underwent coronary angiography and then were divided into 3 groups according to its results: Group A with single vessel lesion, Group B with double vessel lesions, and Group C with triple/left main vessel lesions. Peripheral blood samples were collected to measure the levels of uric acid, C reactive protein, cholesterol, low density lipoprotein cholesterol (LDL-C), high density lipoprotein cholesterol, and triglyceride. Spearman correlation analysis and multiple linear regression were used to analyze the relationship between the risk factors including age, bodyweight, and blood lipids and uric acid. RESULTS: There was significant difference among the three groups at age and LDL-C (both P < 0.05). Age and LDL-C of Group C [(62 +/- 10), (3.0 +/- 0.7) mmol/L] were significantly higher than those of Group A [(59 +/- 11), (2.8 +/- 0.6) mmol/L, both P < 0.05]. Age (r = 0.163) and LDL-C (r = 0.149) were significantly associated with coronary artery stenosis severity (both P < 0. 05). CONCLUSION: The severity of coronary artery stenosis is affected by age and LDL-C. Triple/left main vessel lesions are likely to be seen in the patients with older age and higher blood level of LDL-C.

[Efficacy, safety and tolerance of Felodipine controlled release tablets and Felodipine controlled release tablets associated combination therapy in the treatment of mild to moderate essential hypertension in China].

OBJECTIVE: To evaluate the efficacy, safety and tolerance of Felodipine controlled release tablets and Felodipine controlled release tablets associated combination each with Metoprolol, Lisinopril or Hydrochlorothiazide in the 12 weeks treatment of mild to moderate essential hypertension in China. METHODS: Multicenter, random samples, and open study have been processed. RESULTS: (1)After 12 weeks associated combination treatment of anti-hypertension, the percentages of the persons who had attained the target were 80.2% of ITT group in Felodipine controlled release tablets associated combination with Hydrochlorothiazide, 74.1% of ITT group in with Metoprolol,and 80.5% of ITT group in with Lisinopril, respectively. (2)Mean reductions of systolic/diastolic blood pressure from baseline were 16.8/10.6 mm Hg in combination with Hydrochlorothiazide, 16.6/10.7 mm Hg in combination with Metoprolol,and 18.0/12.8 mm Hg in combination with Lisinopril each. There was no significant difference among these three groups (P>0.05). With the Felodipine controlled release tablets treatment alone, the mean reductions from baseline was 24.8/17.5 mm Hg. But in combination with Lisinopril, the blood pressure could lower more quickly, and then could reach the target more rapidly. (3)In the ITT group, the drug compliance with Felodipine controlled release tablets was 97.7%, with those in combination with Hydrochlorothiazide 89.8%, with those in combination with Metoprolol 100.0%, and with those in combination with Lisinopril 96.4%. The main adverse event related to Felodipine was headache, and to Lisinopril was cough. CONCLUSION: Antihypertensive drug Felodipine controlled release tablets are good and effective. And Felodipine controlled release tablet associated combination each with Metoprolol, Lisinopril or Hydrochlorothiazide can make most patients reach the treatment target, with safety, good tolerance, and high compliance.